Aperio Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $7.83M | Sell |
24,137
-1,021
| -4% | -$331K | 0.02% | 647 |
|
|
2020
Q3 | $6.97M | Buy |
25,158
+993
| +4% | +$275K | 0.02% | 616 |
|
|
2020
Q2 | $5.84M | Sell |
24,165
-3,596
| -13% | -$869K | 0.02% | 674 |
|
|
2020
Q1 | $4.03M | Buy |
27,761
+11,114
| +67% | +$1.61M | 0.02% | 742 |
|
|
2019
Q4 | $2.84M | Sell |
16,647
-633
| -4% | -$108K | 0.01% | 944 |
|
|
2019
Q3 | $3.07M | Sell |
17,280
-2,556
| -13% | -$455K | 0.01% | 877 |
|
|
2019
Q2 | $5.17M | Sell |
19,836
-4,217
| -18% | -$1.1M | 0.02% | 702 |
|
|
2019
Q1 | $6.87M | Buy |
24,053
+203
| +0.9% | +$58K | 0.03% | 577 |
|
|
2018
Q4 | $7.75M | Sell |
23,850
-733
| -3% | -$238K | 0.04% | 483 |
|
|
2018
Q3 | $11.1M | Buy |
24,583
+3,016
| +14% | +$1.36M | 0.05% | 410 |
|
|
2018
Q2 | $8.82M | Buy |
21,567
+1,566
| +8% | +$641K | 0.04% | 478 |
|
|
2018
Q1 | $5.82M | Buy |
20,001
+2,295
| +13% | +$668K | 0.03% | 600 |
|
|
2017
Q4 | $3.32M | Buy |
17,706
+3,977
| +29% | +$745K | 0.02% | 797 |
|
|
2017
Q3 | $2.32M | Buy |
13,729
+531
| +4% | +$89.5K | 0.01% | 881 |
|
|
2017
Q2 | $1.89M | Buy |
13,198
+853
| +7% | +$122K | 0.01% | 934 |
|
|
2017
Q1 | $1.55M | Sell |
12,345
-1,330
| -10% | -$166K | 0.01% | 959 |
|
|
2016
Q4 | $1.54M | Sell |
13,675
-2,402
| -15% | -$271K | 0.01% | 927 |
|
|
2016
Q3 | $2.07M | Buy |
16,077
+4,048
| +34% | +$520K | 0.02% | 824 |
|
|
2016
Q2 | $1.32M | Buy |
12,029
+4,784
| +66% | +$523K | 0.01% | 957 |
|
|
2016
Q1 | $687K | Buy |
7,245
+1,001
| +16% | +$94.9K | 0.01% | 1214 |
|
|
2015
Q4 | $564K | Buy |
6,244
+79
| +1% | +$7.14K | 0.01% | 1271 |
|
|
2015
Q3 | $572K | Buy |
6,165
+335
| +6% | +$31.1K | 0.01% | 1226 |
|
|
2015
Q2 | $383K | Buy |
5,830
+509
| +10% | +$33.4K | ﹤0.01% | 1478 |
|
|
2015
Q1 | $381K | Buy |
+5,321
| New | +$381K | ﹤0.01% | 1428 |
|